Automation Engineer (I, II, III)

We are seeking an Automation Engineer to support the development, validation, and day-to-day operation of fully automated QC testing workflows in a regulated GMP environment at our Bridgewater, NJ site. This role is central to the success of our Cell Q platform and commercial-scale QC operations.

The successful candidate will play a key role in transferring, scaling, and optimizing automated QC test methods across multiple automated workcells, while also providing hands-on runtime operational support for the Cell Q platform and the broader QC laboratory infrastructure. This includes troubleshooting systems, supporting production testing, and ensuring consistent, compliant execution of automated workflows.

Working closely with cross-functional partners in Quality Control, Analytical Development, Manufacturing, IT, and Quality, the Automation Engineer will contribute to system validation, user training, technical documentation, and controlled version management of automated test methods under change control. In addition, this role will help design, implement, and maintain automated sample and reagent management workflows that enable scalable, reliable, and robust end-to-end processes for high-throughput QC testing in a GMP setting.

Candidates should enjoy working in a fast-paced, mission-driven environment and be prepared to tackle a broad range of challenges as the company grows.

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.